• Johnson & Johnson has announced a $5.5 billion settlement to resolve about 76,000 lawsuits.
• The settlement addresses claims that talc in baby powder contributed to ovarian cancer.
• It covers nearly all outstanding talc-related claims in U.S. federal and state courts.
• J&J maintains that claims against its products are "meritless" but seeks closure from litigation.
• The deal, pending approval by claimants, could lead to a total payment of up to $7 billion.

Johnson & Johnson (J&J) announced it will pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging that its baby powder and other talc products cause ovarian cancer. This landmark settlement aims to conclude a lengthy legal battle impacting the company for over ten years, covering approximately 76,000 claims in both federal and state courts, which represents nearly all outstanding talc-related lawsuits against the firm, according to Reuters and Channel News Asia.

J&J's vice president of litigation, Erik Haas, expressed that while the claims lack scientific merit, the settlement provides a pathway to resolution, allowing the company to refocus on its mission. He noted, "This resolution allows the company to put this matter behind it and remain focused on its mission to develop medicines and devices that save lives," as reported by Al Jazeera and BBC.

The court proceedings have seen mixed outcomes for J&J, with significant previous victories, including a recent ruling that cast doubt on whether plaintiffs could prove their claims. This settlement does not cover future lawsuits, which has enabled J&J to concentrate its resources on current claims, as highlighted by CBS News and Bangkok Post.

The plaintiffs' attorneys have welcomed the settlement as a resolution after over a decade of litigation, expressing optimism about compensation for clients. Chris Seeger, an attorney representing many plaintiffs, emphasized that the agreement aims to ensure "fair and meaningful compensation" for those affected, with potential payouts expected to exceed the $5.5 billion figure if more claimants participate, according to reports from Reuters and Channel News Asia.